Bryan, Garnier & Co Analyst Recommendations & Stock Picks This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Bryan, Garnier & Co. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Bryan, Garnier & Co. Country All Countries United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Europe Australia Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap MarketRank evaluates a company based on community opinion, dividend strength, institutional and insider ownership, earnings and valuation, and analysts forecasts.Available with a MarketBeat All Access SubscriptionMarketRank™Upgrade to All Access to use the All Ranks Filter Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.Available with a MarketBeat All Access SubscriptionMedia SentimentUpgrade to All Access to use the All Sentiments Filter Analyst consensus is the average investment recommendation among Wall Street research analysts.Available with a MarketBeat All Access SubscriptionAnalyst ConsensusUpgrade to All Access to use the All Ratings Filter Export to Excel CompanyDateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActionsTVTXTravere Therapeutics5/5/2023Upgraded byBryan, Garnier & CoSell -> NeutralLowIMCRImmunocore3/24/2023Initiated byBryan, Garnier & CoBuy $16.00LowIMTXImmatics3/24/2023Initiated byBryan, Garnier & CoBuy $16.00LowADAPAdaptimmune Therapeutics3/24/2023Initiated byBryan, Garnier & CoBuy $3.60LowCRSPCRISPR Therapeutics3/17/2023Initiated byBryan, Garnier & CoBuy $70.00LowCLLSCellectis3/17/2023Initiated byBryan, Garnier & CoBuy $6.00LowAUTLAutolus Therapeutics3/17/2023Initiated byBryan, Garnier & CoBuy $5.00LowMLTXMoonLake Immunotherapeutics2/2/2023Initiated byBryan, Garnier & CoBuy $22.00LowSAPSAP12/14/2022Target Set byBryan, Garnier & CoAnalyst Gregory Ramirez €130.00N/ACRRFYCarrefour11/16/2022Downgraded byBryan, Garnier & CoAnalyst Clement GenelotBuy -> Neutral€22.00 -> €20.00LowPHVSPharvaris10/5/2022Initiated byBryan, Garnier & CoBuy $16.00LowTVTXTravere Therapeutics9/21/2022Initiated byBryan, Garnier & CoSell $17.00LowTAPMolson Coors Beverage9/1/2022Downgraded byBryan, Garnier & CoAnalyst Nikolaas FaesBuy -> Sell $54.00LowADRNYKoninklijke Ahold Delhaize8/31/2022Upgraded byBryan, Garnier & CoAnalyst Clement GenelotNeutral -> Buy€31.00 -> €34.00LowADYEYAdyen8/19/2022Downgraded byBryan, Garnier & CoBuy -> NeutralLowCMPGYCompass Group6/9/2022Upgraded byBryan, Garnier & CoNeutral -> BuyMediumZLNDYZalando6/1/2022Downgraded byBryan, Garnier & CoAnalyst Clement GenelotNeutral -> Sell€87.00 -> €38.00HighGMABGenmab A/S5/13/2022Upgraded byBryan, Garnier & CoAnalyst Victor FlochSell -> NeutralMediumNVONovo Nordisk A/S5/5/2022Upgraded byBryan, Garnier & CoSell -> NeutralLowBLDRBuilders FirstSource4/6/2022Downgraded byBryan, Garnier & CoBuy -> Neutral $71.00HighHNNMYH & M Hennes & Mauritz AB (publ)4/4/2022Downgraded byBryan, Garnier & CoAnalyst Cedric RossiBuy -> NeutralSEK 225 -> SEK 190LowSDXAYSodexo3/25/2022Downgraded byBryan, Garnier & CoAnalyst Bruno De La RochebrochardStrong-Buy -> Buy €95.00LowMTLSMaterialise3/25/2022Downgraded byBryan, Garnier & CoAnalyst Gregory RamirezBuy -> Neutral $20.00LowDASTYDassault Systèmes3/25/2022Downgraded byBryan, Garnier & CoAnalyst Gregory RamirezBuy -> Neutral €49.00HighTIIAYTelecom Italia3/14/2022Upgraded byBryan, Garnier & CoAnalyst Thomas CoudryNeutral -> BuyMediumZLNDYZalando3/4/2022Downgraded byBryan, Garnier & CoNeutralHighGLPGGalapagos1/28/2022Upgraded byBryan, Garnier & CoSell -> BuyHighNVSNovartis12/3/2021Reiterated byBryan, Garnier & CoAnalyst Jeanjacques LeBuy -> Neutral$115.00 -> $85.00LowAZNAstraZeneca11/22/2021Downgraded byBryan, Garnier & CoBuyLowNVONovo Nordisk A/S11/3/2021Downgraded byBryan, Garnier & CoAnalyst Jean-Jacques LeBuy -> Sell 592.00HighESLOYEssilorLuxottica Société anonyme10/29/2021Upgraded byBryan, Garnier & CoAnalyst Cedric RossiNeutral -> BuyHighMTTRYCeconomy10/12/2021Downgraded byBryan, Garnier & CoAnalyst Clement GenelotBuy -> NeutralLowBNTXBioNTech10/5/2021Target Set byBryan, Garnier & CoAnalyst Olga Smolentseva $359.00LowBNTXBioNTech9/24/2021Target Set byBryan, Garnier & CoAnalyst Olga Smolentseva $451.00HighVALNValneva9/13/2021Downgraded byBryan, Garnier & CoAnalyst Jean-Jacques Le FurBuy -> NeutralHighERFSFEurofins Scientific8/25/2021Downgraded byBryan, Garnier & CoAnalyst Bruno DeStrong-Buy -> NeutralLowBNTXBioNTech8/11/2021Upgraded byBryan, Garnier & CoAnalyst Olga SmolentsevaNeutral -> BuyHighBOUYFBouygues7/27/2021Upgraded byBryan, Garnier & CoAnalyst Thomas CoudryNeutral -> Buy $37.20LowAEXAYAtos7/13/2021Downgraded byBryan, Garnier & CoAnalyst Gregory RamirezBuy -> SellMediumERFSFEurofins Scientific7/9/2021Downgraded byBryan, Garnier & CoAnalyst Bruno DeBuy -> NeutralHighMORMorphoSys6/3/2021Downgraded byBryan, Garnier & CoBuy -> NeutralMediumBNTXBioNTech5/17/2021Reiterated byBryan, Garnier & CoBuy -> Neutral$135.00 -> $206.00N/ABNTXBioNTech5/11/2021Downgraded byBryan, Garnier & CoBuy -> Neutral$135.00 -> $206.00LowBUDAnheuser-Busch InBev SA/NV5/6/2021Upgraded byBryan, Garnier & CoSell -> BuyMediumDBVTDBV Technologies5/3/2021Upgraded byBryan, Garnier & CoSell -> BuyLowAEXAYAtos4/6/2021Downgraded byBryan, Garnier & CoBuyLowTCLRYVantiva3/31/2021Initiated byBryan, Garnier & CoBuyMediumMTLSMaterialise3/10/2021Upgraded byBryan, Garnier & CoNeutral -> Buy $43.00HighECIFYElectricité de France2/24/2021Downgraded byBryan, Garnier & CoNeutral -> SellLowGNFTGenfit2/12/2021Upgraded byBryan, Garnier & CoNeutral -> BuyLowIPHYFInnate Pharma2/9/2021Upgraded byBryan, Garnier & CoNeutral -> BuyLowDASTYDassault Systèmes2/5/2021Upgraded byBryan, Garnier & CoSell -> BuyLowSDXAYSodexo2/3/2021Upgraded byBryan, Garnier & CoNeutral -> BuyLowVCISYVinci1/14/2021Upgraded byBryan, Garnier & CoSell -> NeutralMediumIFNNYInfineon Technologies1/14/2021Downgraded byBryan, Garnier & CoBuy -> NeutralLowSTMSTMicroelectronics1/8/2021Upgraded byBryan, Garnier & CoNeutral -> BuyHighGLPGGalapagos12/17/2020Downgraded byBryan, Garnier & CoBuy -> SellHighSCRYYScor12/17/2020Downgraded byBryan, Garnier & CoBuyLowITMPFITM Power12/11/2020Initiated byBryan, Garnier & CoBuyLowSTMSTMicroelectronics12/10/2020Downgraded byBryan, Garnier & CoBuy -> NeutralLowGMABGenmab A/S9/23/2020Downgraded byBryan, Garnier & CoNeutral -> SellHighIHGInterContinental Hotels Group9/21/2020Downgraded byBryan, Garnier & CoNeutral -> SellLowIPHAInnate Pharma9/9/2020Downgraded byBryan, Garnier & CoBuy -> NeutralLowDBVTDBV Technologies8/4/2020Downgraded byBryan, Garnier & CoNeutral -> SellHighBUDAnheuser-Busch InBev SA/NV7/15/2020Downgraded byBryan, Garnier & CoBuy -> SellLowTAPMolson Coors Beverage7/15/2020Upgraded byBryan, Garnier & CoSell -> Buy $49.00LowDEODiageo7/8/2020Upgraded byBryan, Garnier & CoNeutral -> BuyLowBNTXBioNTech7/2/2020Target Raised byBryan, Garnier & Co$50.00 -> $62.00HighHEXOHEXO7/1/2020Downgraded byBryan, Garnier & CoBuy -> SellMediumSTMSTMicroelectronics6/29/2020Upgraded byBryan, Garnier & CoNeutral -> BuyLowGMABGenmab A/S6/3/2020Downgraded byBryan, Garnier & CoBuy -> NeutralLowAZNAstraZeneca6/2/2020Target Raised byBryan, Garnier & CoBuyGBX 8,780 -> GBX 9,100N/ACGCCanopy Growth6/1/2020Downgraded byBryan, Garnier & CoNeutral -> SellHighGNFTGenfit5/13/2020Downgraded byBryan, Garnier & CoBuy -> NeutralMediumAZNAstraZeneca5/11/2020Target Raised byBryan, Garnier & CoBuyGBX 8,550 -> GBX 8,780N/AORANOrange3/27/2020Upgraded byBryan, Garnier & CoNeutral -> BuyLowDBVTDBV Technologies3/18/2020Downgraded byBryan, Garnier & CoBuy -> NeutralHighSGEThe Sage Group3/2/2020Target Lowered byBryan, Garnier & CoNeutralGBX 690 -> GBX 680N/ABUDAnheuser-Busch InBev SA/NV2/28/2020Downgraded byBryan, Garnier & CoBuy -> NeutralHighACBAurora Cannabis2/27/2020Downgraded byBryan, Garnier & CoNeutral -> SellLowGSKGSK2/6/2020Target Lowered byBryan, Garnier & CoNeutralGBX 1,800 -> GBX 1,773N/ASAPSAP1/28/2020Target Set byBryan, Garnier & CoBuy €153.00N/AASMLASML1/14/2020Upgraded byBryan, Garnier & CoNeutral -> BuyMediumBRBYBurberry Group1/10/2020Target Raised byBryan, Garnier & CoNeutralGBX 1,780 -> GBX 1,860N/AAZNAstraZeneca12/19/2019Reiterated byBryan, Garnier & CoBuyN/AGSKGSK12/19/2019Target Raised byBryan, Garnier & CoNeutralGBX 1,660 -> GBX 1,747N/AORANOrange12/5/2019Downgraded byBryan, Garnier & CoBuy -> NeutralLowAZNAstraZeneca11/25/2019Upgraded byBryan, Garnier & CoBuyGBX 7,700 -> GBX 7,950N/ACABGYCarlsberg A/S8/12/2019Upgraded byBryan, Garnier & CoNeutral -> BuyLowTAPMolson Coors Beverage8/1/2019Reiterated byBryan, Garnier & CoNeutral -> Sell $51.00HighCGCCanopy Growth7/5/2019Downgraded byBryan, Garnier & CoBuy -> NeutralLowWEEDCanopy Growth7/4/2019Downgraded byBryan, Garnier & CoBuy -> NeutralC$85.00 -> C$60.00N/AAZNAstraZeneca7/3/2019Reiterated byBryan, Garnier & CoNeutralN/ASCHSafeCharge International Group5/24/2019Reiterated byBryan, Garnier & CoBuyN/ABURBYBurberry Group5/20/2019Upgraded byBryan, Garnier & CoSell -> NeutralLowBRBYBurberry Group5/20/2019Upgraded byBryan, Garnier & CoNeutralN/AADDYYadidas5/6/2019Downgraded byBryan, Garnier & CoBuy -> NeutralHighGSKGSK5/2/2019Target Lowered byBryan, Garnier & CoNeutralGBX 1,710 -> GBX 1,660N/APDRDYPernod Ricard3/29/2019Downgraded byBryan, Garnier & CoBuy -> NeutralLowAZNAstraZeneca3/29/2019Reiterated byBryan, Garnier & CoNeutralN/AAZNAstraZeneca2/22/2019Downgraded byBryan, Garnier & CoNeutralN/AIHGInterContinental Hotels Group2/19/2019Reiterated byBryan, Garnier & CoSellN/ASGEThe Sage Group1/17/2019Target Lowered byBryan, Garnier & CoBuyGBX 850 -> GBX 630N/AAZNAstraZeneca11/8/2018Downgraded byBryan, Garnier & CoNeutralN/ASCHSafeCharge International Group9/13/2018Target Raised byBryan, Garnier & CoBuyGBX 354 -> GBX 380N/ALVMUYLVMH Moët Hennessy - Louis Vuitton, Société Européenne4/24/2018Upgraded byBryan, Garnier & CoNeutral -> BuyMediumSOWSoftware Aktiengesellschaft4/17/2018Target Set byBryan, Garnier & CoBuy €49.00N/AMORMorphoSys4/9/2018Target Set byBryan, Garnier & CoBuy €91.00N/ASAPSAP4/6/2018Target Set byBryan, Garnier & CoBuy €112.00N/AMORMorphoSys3/14/2018Target Set byBryan, Garnier & CoBuy €91.20N/AIGYinnogy SE (IGY.F)3/12/2018Target Set byBryan, Garnier & CoNeutral €31.00N/AIHGInterContinental Hotels Group2/20/2018Reiterated byBryan, Garnier & CoSell GBX 4,100N/AONCOncimmune2/13/2018Target Raised byBryan, Garnier & CoBuyGBX 154 -> GBX 168N/ADGEDiageo1/25/2018Reiterated byBryan, Garnier & CoNeutral GBX 2,320N/ASGEThe Sage Group1/25/2018Target Lowered byBryan, Garnier & CoBuyGBX 860 -> GBX 850N/AAZNAstraZeneca12/15/2017Reiterated byBryan, Garnier & CoBuyN/ASGEThe Sage Group11/23/2017Target Raised byBryan, Garnier & CoBuyGBX 830 -> GBX 860N/ABRBYBurberry Group11/10/2017Reiterated byBryan, Garnier & CoSellN/AULVRUnilever10/20/2017Reiterated byBryan, Garnier & CoNeutral GBX 4,350N/AMBGAFMercedes-Benz Group9/25/2017Initiated byBryan, Garnier & CoBuyLowSGPYYThe Sage Group9/24/2017Upgraded byBryan, Garnier & CoNeutral -> BuyN/ASGPYYThe Sage Group9/22/2017Upgraded byBryan, Garnier & CoNeutral -> BuyLowSGEThe Sage Group9/22/2017Upgraded byBryan, Garnier & CoBuyGBX 720 -> GBX 830N/AGSKGSK9/19/2017Reiterated byBryan, Garnier & CoNeutral GBX 1,710N/ATSCOTesco9/12/2017Reiterated byBryan, Garnier & CoSell GBX 170N/AAZNAstraZeneca9/11/2017Upgraded byBryan, Garnier & CoBuyGBX 4,700 -> GBX 5,380N/ABRBYBurberry Group9/11/2017Reiterated byBryan, Garnier & CoSellN/A8888889/5/2017Reiterated byBryan, Garnier & CoBuy GBX 330N/ACPGCompass Group8/29/2017Reiterated byBryan, Garnier & CoNeutral GBX 1,550N/AULVRUnilever8/25/2017Reiterated byBryan, Garnier & CoNeutral GBX 4,300N/AIHGInterContinental Hotels Group8/24/2017Reiterated byBryan, Garnier & CoSell GBX 3,520N/ADGEDiageo8/23/2017Target Raised byBryan, Garnier & CoNeutralGBX 2,210 -> GBX 2,320N/AGSKGSK7/26/2017Target Raised byBryan, Garnier & CoBuyGBX 1,750 -> GBX 1,790N/AGSKGSK7/20/2017Reiterated byBryan, Garnier & CoBuy GBX 1,750N/ATSCOTesco6/20/2017Reiterated byBryan, Garnier & CoSell GBX 170N/ATSCOTesco6/14/2017Reiterated byBryan, Garnier & CoSell GBX 170N/AGSKGSK5/31/2017Reiterated byBryan, Garnier & CoBuy GBX 1,750N/ABRBYBurberry Group4/20/2017Reiterated byBryan, Garnier & CoSellN/ABRBYBurberry Group4/13/2017Reiterated byBryan, Garnier & CoSell GBX 1,350N/ATSCOTesco4/13/2017Reiterated byBryan, Garnier & CoSell GBX 170N/ATSCOTesco3/23/2017Reiterated byBryan, Garnier & CoSell GBX 170N/ADGEDiageo3/17/2017Reiterated byBryan, Garnier & CoNeutral GBX 2,210N/ASGEThe Sage Group3/6/2017Target Raised byBryan, Garnier & CoNeutralGBX 640 -> GBX 660N/AAZNAstraZeneca2/28/2017Reiterated byBryan, Garnier & CoBuy GBX 5,400N/AIHGInterContinental Hotels Group2/21/2017Reiterated byBryan, Garnier & CoSell GBX 2,950N/ACPGCompass Group2/3/2017Reiterated byBryan, Garnier & CoNeutral GBX 1,475N/ASGEThe Sage Group2/1/2017Reiterated byBryan, Garnier & CoNeutral GBX 640N/ATSCOTesco1/30/2017Reiterated byBryan, Garnier & CoSell GBX 170N/AULVRUnilever1/27/2017Reiterated byBryan, Garnier & CoNeutral GBX 3,570N/ADGEDiageo1/26/2017Reiterated byBryan, Garnier & CoNeutral GBX 2,150N/ASGEThe Sage Group1/26/2017Reiterated byBryan, Garnier & CoNeutral GBX 650N/ABRBYBurberry Group1/18/2017Reiterated byBryan, Garnier & CoSell GBX 1,350N/ADGEDiageo1/16/2017Reiterated byBryan, Garnier & CoNeutral GBX 2,150N/AMRKMerck & Co., Inc.1/13/2017Initiated byBryan, Garnier & CoBuyN/ABRBYBurberry Group1/10/2017Reiterated byBryan, Garnier & CoSell GBX 1,350N/ACPGCompass Group1/9/2017Reiterated byBryan, Garnier & CoNeutral GBX 1,430N/AAZNAstraZeneca1/9/2017Reiterated byBryan, Garnier & CoBuy GBX 5,250N/AGSKGSK1/9/2017Reiterated byBryan, Garnier & CoBuy GBX 1,850N/APNNPennon Group1/6/2017Reiterated byBryan, Garnier & CoSell GBX 830N/ABRBYBurberry Group1/4/2017Downgraded byBryan, Garnier & CoSell GBX 1,350N/ADGEDiageo1/4/2017Reiterated byBryan, Garnier & CoNeutral GBX 2,150N/AULVRUnilever1/4/2017Reiterated byBryan, Garnier & CoNeutral GBX 3,990N/ATSCOTesco1/4/2017Reiterated byBryan, Garnier & CoSell GBX 170N/AAZNAstraZeneca12/12/2016Reiterated byBryan, Garnier & CoBuy GBX 5,100N/ASGEThe Sage Group11/30/2016Reiterated byBryan, Garnier & CoSell GBX 690N/ACMPGYCompass Group11/25/2016Reiterated byBryan, Garnier & CoNeutralN/ADGEDiageo11/23/2016Reiterated byBryan, Garnier & CoNeutralN/AAZNAstraZeneca11/22/2016Reiterated byBryan, Garnier & CoBuy GBX 5,100N/ACPGCompass Group11/22/2016Reiterated byBryan, Garnier & CoNeutral GBX 1,450N/AAZNAstraZeneca10/26/2016Reiterated byBryan, Garnier & CoBuy GBX 5,220N/ABRBYBurberry Group10/25/2016Target Raised byBryan, Garnier & CoNeutralGBX 1,260 -> GBX 1,350N/ABRBYBurberry Group10/19/2016Target Raised byBryan, Garnier & CoNeutralGBX 1,200 -> GBX 1,250N/AAZNAstraZeneca10/17/2016Reiterated byBryan, Garnier & CoBuy GBX 5,220N/AGSKGSK10/17/2016Reiterated byBryan, Garnier & CoBuyN/ASGEThe Sage Group10/12/2016Target Raised byBryan, Garnier & CoSellGBX 600 -> GBX 690N/ATSCOTesco10/5/2016Reiterated byBryan, Garnier & CoSell GBX 166N/AAZNAstraZeneca10/4/2016Target Lowered byBryan, Garnier & CoBuyGBX 5,400 -> GBX 5,220N/ASGEThe Sage Group9/30/2016Reiterated byBryan, Garnier & CoSell GBX 600N/AIHGInterContinental Hotels Group9/27/2016Downgraded byBryan, Garnier & CoSellGBX 2,650 -> GBX 2,950N/AAZNAstraZeneca7/28/2016Reiterated byBryan, Garnier & CoBuyN/AGSKGSK7/28/2016Reiterated byBryan, Garnier & CoBuyN/ATAPMolson Coors Beverage7/8/2016Upgraded byBryan, Garnier & CoBuyN/ASGEThe Sage Group5/5/2016Reiterated byBryan, Garnier & CoSell GBX 550N/ATSCOTesco4/4/2016Reiterated byBryan, Garnier & CoNeutral GBX 166N/ACPGCompass Group4/4/2016Reiterated byBryan, Garnier & CoNeutral GBX 1,200N/AAZNAstraZeneca3/10/2016Reiterated byBryan, Garnier & CoBuy GBX 5,520N/APNNPennon Group2/11/2016Downgraded byBryan, Garnier & CoSell GBX 825N/APNNPennon Group2/4/2016Reiterated byBryan, Garnier & CoNeutral GBX 800N/ASGEThe Sage Group1/28/2016Reiterated byBryan, Garnier & CoNeutral GBX 570N/AGSKGSK1/27/2016Upgraded byBryan, Garnier & CoNeutral -> BuyN/AGSKGSK1/27/2016Upgraded byBryan, Garnier & CoBuy GBX 1,635N/AASMLASML1/21/2016Upgraded byBryan, Garnier & CoNeutral -> BuyN/ATSCOTesco1/14/2016Initiated byBryan, Garnier & CoNeutral GBX 166N/APNNPennon Group1/8/2016Reiterated byBryan, Garnier & CoNeutral GBX 800N/AIHGInterContinental Hotels Group1/7/2016Reiterated byBryan, Garnier & CoNeutral GBX 2,650N/ACPGCompass Group1/5/2016Target Raised byBryan, Garnier & CoNeutralGBX 1,150 -> GBX 1,200N/ASGEThe Sage Group12/18/2015Reiterated byBryan, Garnier & CoNeutral GBX 540N/AGLPGGalapagos12/17/2015Target Raised byBryan, Garnier & CoBuy$52.00 -> $64.00N/ADGEDiageo12/3/2015Reiterated byBryan, Garnier & CoNeutral GBX 1,870N/ATSCOTesco12/1/2015Reiterated byBryan, Garnier & CoNeutralN/APNNPennon Group11/27/2015Reiterated byBryan, Garnier & CoNeutral GBX 800N/ASGEThe Sage Group11/27/2015Reiterated byBryan, Garnier & CoNeutral GBX 540N/ATSCDYTesco11/25/2015Reiterated byBryan, Garnier & CoNeutralN/ATSCOTesco11/25/2015Initiated byBryan, Garnier & CoNeutralN/ACPGCompass Group11/24/2015Reiterated byBryan, Garnier & CoNeutral GBX 1,150N/ATAPMolson Coors Beverage11/17/2015Initiated byBryan, Garnier & CoBuy $101.00N/ASGEThe Sage Group11/13/2015Reiterated byBryan, Garnier & CoNeutral GBX 540N/AAZNAstraZeneca11/12/2015Target Raised byBryan, Garnier & CoBuyGBX 5,100 -> GBX 5,150N/ASNYSanofi11/9/2015Reiterated byBryan, Garnier & CoBuy -> NeutralN/APNNPennon Group10/26/2015Reiterated byBryan, Garnier & CoNeutral GBX 800N/AAZNAstraZeneca10/23/2015Reiterated byBryan, Garnier & CoBuy GBX 5,100N/AUBSFYUbisoft Entertainment10/15/2015Upgraded byBryan, Garnier & CoNeutral -> BuyN/AAZNAstraZeneca10/12/2015Reiterated byBryan, Garnier & CoBuy GBX 5,400N/ASGEThe Sage Group10/6/2015Reiterated byBryan, Garnier & CoNeutral GBX 520N/AIHGInterContinental Hotels Group10/5/2015Reiterated byBryan, Garnier & CoNeutralN/ADGEDiageo10/1/2015Reiterated byBryan, Garnier & CoNeutral GBX 1,870N/ADGEDiageo9/23/2015Target Lowered byBryan, Garnier & CoNeutralGBX 1,920 -> GBX 1,870N/AAZNAstraZeneca9/18/2015Upgraded byBryan, Garnier & CoNeutral -> BuyN/AAZNAstraZeneca9/10/2015Reiterated byBryan, Garnier & CoNeutral GBX 4,830N/AGSKGSK9/9/2015Target Lowered byBryan, Garnier & CoNeutralGBX 1,480 -> GBX 1,470N/APNNPennon Group8/25/2015Reiterated byBryan, Garnier & CoNeutral GBX 835N/AGSKGSK8/21/2015Reiterated byBryan, Garnier & CoNeutral GBX 1,480N/AAZNAstraZeneca8/21/2015Reiterated byBryan, Garnier & CoNeutral GBX 4,830N/ADGEDiageo7/29/2015Reiterated byBryan, Garnier & CoNeutral GBX 1,920N/ASGEThe Sage Group7/21/2015Reiterated byBryan, Garnier & CoNeutral GBX 520N/AVCISYVinci7/17/2015Initiated byBryan, Garnier & CoBuyN/ADANOYDanone7/8/2015Initiated byBryan, Garnier & CoBuyN/ADGEDiageo7/2/2015Reiterated byBryan, Garnier & CoNeutral GBX 1,920N/ADASTYDassault Systèmes6/30/2015Downgraded byBryan, Garnier & CoNeutral -> SellN/ANVSNovartis6/22/2015Upgraded byBryan, Garnier & CoNeutral -> BuyN/AIFNNYInfineon Technologies6/11/2015Initiated byBryan, Garnier & CoBuyN/ADLGNFDialog Semiconductor6/11/2015Initiated byBryan, Garnier & CoBuyN/AGSKGSK6/2/2015Reiterated byBryan, Garnier & CoNeutral GBX 1,580N/AIHGInterContinental Hotels Group5/21/2015Reiterated byBryan, Garnier & CoNeutral GBX 2,650N/AUBSFYUbisoft Entertainment5/13/2015Downgraded byBryan, Garnier & CoBuy -> NeutralN/ADGEDiageo5/6/2015Reiterated byBryan, Garnier & CoNeutral GBX 1,950N/ACABGYCarlsberg A/S5/5/2015Initiated byBryan, Garnier & CoNeutralN/ABUDAnheuser-Busch InBev SA/NV5/5/2015Initiated byBryan, Garnier & CoNeutralN/AAEGAegon4/15/2015Upgraded byBryan, Garnier & CoNeutral -> BuyN/AAZNAstraZeneca4/10/2015Reiterated byBryan, Garnier & CoNeutral GBX 4,740N/ADGEDiageo4/1/2015Target Raised byBryan, Garnier & CoNeutralGBX 1,880 -> GBX 2,000N/ACPGCompass Group3/30/2015Target Raised byBryan, Garnier & CoNeutralGBX 1,070 -> GBX 1,220N/ANVONovo Nordisk A/S3/26/2015Downgraded byBryan, Garnier & CoNeutralN/APPRUYKering2/18/2015Downgraded byBryan, Garnier & CoNeutralN/ALVMUYLVMH Moët Hennessy - Louis Vuitton, Société Européenne2/4/2015Upgraded byBryan, Garnier & CoBuyN/ASGEThe Sage Group1/29/2015Reiterated byBryan, Garnier & CoNeutral GBX 450N/ARHHBYRoche1/28/2015Upgraded byBryan, Garnier & CoBuyN/ASAPSAP1/20/2015Downgraded byBryan, Garnier & CoBuy -> NeutralN/ASGEThe Sage Group1/13/2015Reiterated byBryan, Garnier & CoNeutral GBX 420N/AFMSFresenius Medical Care AG & Co. KGaA12/18/2014Downgraded byBryan, Garnier & CoNeutralN/A MarketBeat Community Rating for Bryan, Garnier & CoCommunity Ranking: 2.7 out of 5 (2.7 of 5 stars)Outperform Votes: 20,366 (Vote Outperform)Underperform Votes: 17,004 (Vote Underperform)Total Votes: 37,370MarketBeat's community ratings are surveys of what our community members think about Bryan, Garnier & Co and other research firms. Vote "Outperform" if you believe Bryan, Garnier & Co's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Bryan, Garnier & Co's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days. Stock Ratings Reports and Tools Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings European Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools: Stock Ratings by Company Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Ratings for Popular Stocks: Alphabet (Google) Amazon Apple Meta (Facebook) Microsoft Netflix Nvidia Tesla Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.